These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 7148507)

  • 1. Hypercalcemia due to primary hyperparathyroidism or malignant disease. Evaluated by means of biochemical tests and the steroid suppression test.
    Kvetny J; Orthman-Brask H; Frederiksen PK; Jest P; Jensen E; Jacobsen JG
    Acta Med Scand; 1982; 212(3):163-6. PubMed ID: 7148507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum chloride in the differential diagnosis of hypercalcemia.
    Lind L; Ljunghall S
    Exp Clin Endocrinol; 1991; 98(3):179-84. PubMed ID: 1778237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of hypercalcemia.
    Lafferty FW
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S51-9; discussion S61. PubMed ID: 1763670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloride/phosphate ratio in primary hyperparathyroidism.
    Boughey JC; Ewart CJ; Yost MJ; Nottingham JM; Brown JJ
    Am Surg; 2004 Jan; 70(1):25-8. PubMed ID: 14964541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological research on primary hyperparathyroidism. A prospective multicenter study].
    Niederle B; Roka R; Woloszczuk W; Schernthaner G; Schubert E; Borek E; Karner A; Hirsch E; Seidl F; Pesendorfer F
    Dtsch Med Wochenschr; 1988 Feb; 113(5):163-8. PubMed ID: 3338398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential laboratory diagnosis of hypercalcemia.
    Johnson KR; Mascall GC; Howarth AT
    Crit Rev Clin Lab Sci; 1984; 21(1):51-97. PubMed ID: 6386333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary hyperparathyroidism associated with sarcoidosis].
    Tomita A
    Nihon Rinsho; 1995 Apr; 53(4):949-52. PubMed ID: 7752490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hyperparathyroidism. Current aspects of its diagnosis apropos of a case with digestive and neuropsychiatric manifestations].
    Sebert JL; Dupont A; Fournier A; Coevoet B; Lambrey G; Ghighi J; Quichaud J
    Sem Hop; 1978 Dec 18-25; 54(45-46):1488-93. PubMed ID: 219510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normocalcemic hyperparathyroidism in patients with osteoporosis.
    Monchik JM; Gorgun E
    Surgery; 2004 Dec; 136(6):1242-6. PubMed ID: 15657582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of hypercalcemia. Significance of the determination of intact parathyroid hormone for differential diagnosis].
    Blind E; Raue F; Zisterer A; Kohl B; Ziegler R
    Dtsch Med Wochenschr; 1990 Nov; 115(46):1739-45. PubMed ID: 2226185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypocalciuric hypercalcemia: description of a new kindred with emphasis on its difference from primary hyperparathyroidism.
    Gilbert F; D'Amour P; Gascon-Barré M; Boutin JM; Havramkova J; Bélanger R; Matte R
    Clin Invest Med; 1985; 8(1):78-84. PubMed ID: 2985312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypercalcemia is the most common manifestation of hyperparathyroidism].
    Yuzawa Y; Watanabe Y
    Nihon Rinsho; 1995 Apr; 53(4):864-9. PubMed ID: 7752474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature.
    Robert JH; Trombetti A; Garcia A; Pache JC; Herrmann F; Spiliopoulos A; Rizzoli R
    Ann Surg Oncol; 2005 Jul; 12(7):526-32. PubMed ID: 15889214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic problems with recognition of primary hyperparathyroidism].
    Gołkowski F; Jabrocka-Hybel A; Trofimiuk M; Huszno B
    Przegl Lek; 2005; 62(7):685-9. PubMed ID: 16463702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of asymptomatic hypercalcemia].
    Koller M
    Schweiz Med Wochenschr; 1985 May; 115(21):733-7. PubMed ID: 4012249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.
    Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE
    N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries. How should you evaluate elevated calcium in an asymptomatic patient?
    Sharma B; Misicko NE; Hitchcock K; Neher JO
    J Fam Pract; 2008 Apr; 57(4):267-9. PubMed ID: 18394361
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer.
    Riggs BL; Arnaud CD; Reynolds JC; Smith LH
    J Clin Invest; 1971 Oct; 50(10):2079-83. PubMed ID: 4330004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.